Literature DB >> 3105568

Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.

B Silke, M A Frais, S P Verma, G W Reynolds, M Hafizullah, P A Kalra, N C Jackson, S H Taylor.   

Abstract

A prospective study evaluated the comparative haemodynamic effects of three Class I antiarrhythmics (lignocaine Class 1B, disopyramide Class 1A and flecainide Class 1C) in 30 patients with uncomplicated acute myocardial infarction. Three groups, each of 10 patients, were allocated to lignocaine (Group I) 1.5 mg kg-1 i.v. loading dose over 10 min followed by infusion at 3 mg kg-1 h-1, disopyramide (Group II) or flecainide (Group III), both administered as a 1.0 mg kg-1 i.v. loading bolus over 10 min followed by a 1.6 mg kg-1 h-1 infusion for 120 min. The plasma levels of each drug were in the described therapeutic range. Lignocaine decreased cardiac index (-0.3 l min-1 m-2 (9%); P less than 0.05) and stroke volume index (-5 ml m-2 (11%); P less than 0.01). Systemic blood pressure, heart rate and systemic vascular resistance index were unchanged. There was a small increase (+3 mm Hg (30%); P less than 0.01) in pulmonary artery occluded pressure (PAOP). Both disopyramide and flecainide increased systemic blood pressure; the maximum increases for mean blood pressure were +10 mm Hg (11%) and +4 mm Hg (4%) respectively. Both drugs reduced cardiac index (-0.5 l min-1 m-2 (16%): -0.4 l min-1 m-2 (11%)) and stroke volume index (-11 ml m-2 (25%): -5 ml m-2 (11%)). There were increases in heart rate (+13: +5 beats min-1) pulmonary artery occluded pressure (+2: +3 mm Hg) and systemic vascular resistance index (+696: +275 dyn s cm-5 m2).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3105568      PMCID: PMC1401214          DOI: 10.1111/j.1365-2125.1986.tb02961.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  Disopyramide.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1979-04-26       Impact factor: 91.245

2.  Hemodynamic effects of procainamide in patients with acute myocardial infarction and comparison with lidocaine.

Authors:  R R Miller; G Hilliard; J E Lies; R A Massumi; R Zelis; D T Mason; E A Amsterdam
Journal:  Am J Med       Date:  1973-08       Impact factor: 4.965

3.  Hemodynamic effects of lidocaine in patients with heart disease.

Authors:  R R Schumacher; A D Lieberson; R H Childress; J F Williams
Journal:  Circulation       Date:  1968-06       Impact factor: 29.690

4.  Lidocaine infusion in acute myocardial infarction. Effects on left ventricular function.

Authors:  S H Rahimtoola; M Z Sinno; H S Loeb; R Chuquimia; K M Rosen; R M Gunnar
Journal:  Arch Intern Med       Date:  1971-09

5.  Cardiovascular effects of infusion of lidocaine on patients with heart disease.

Authors:  J I Grossman; J A Cooper; J Frieden
Journal:  Am J Cardiol       Date:  1969-08       Impact factor: 2.778

6.  [The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) (author's transl)].

Authors:  O A Beck; J Vogt; H Hochrein
Journal:  Z Kardiol       Date:  1978-01

7.  Simultaneous liquid-chromatographic determination of three antiarrhythmic drugs: disopyramide, lidocaine, and quinidine.

Authors:  J G Flood; G N Bowers; R B McComb
Journal:  Clin Chem       Date:  1980-02       Impact factor: 8.327

8.  Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.

Authors:  V Kötter; T Linderer; R Schröder
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

9.  Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.

Authors:  J Hulting; G Rosenhamer
Journal:  Acta Med Scand       Date:  1976

10.  Disopyramide: serum level and arrhythmia conversion.

Authors:  A P Niarchos
Journal:  Am Heart J       Date:  1976-07       Impact factor: 4.749

View more
  3 in total

1.  Effects of flecainide on isolated vascular smooth muscles of rat.

Authors:  F Pérez-Vizcaino; J Duarte; J Tamargo
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

2.  Flecainide is effective against premature supraventricular and ventricular contractions during general anesthesia.

Authors:  T Saishu; N Iwatsuki; T Tajima; Y Hashimoto
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

3.  Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants.

Authors:  Chunyun Du; Yihong Zhang; Aziza El Harchi; Christopher E Dempsey; Jules C Hancox
Journal:  J Mol Cell Cardiol       Date:  2014-05-27       Impact factor: 5.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.